Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, ...
The average one-year price target for Zenas BioPharma (NasdaqGS:ZBIO) has been revised to $41.56 / share. This is a decrease ...
AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, Haisco will hold a 19.9% equity stake in the biotech, while also earning the ...
AirNexis Therapeutics is a clinical-stage biotech company developing novel therapeutic drugs for the treatment of COPD patients. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through ...
AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, today announced the close of a $200 million Series A financing round and the in-license of a ...
Company founded by Frazier Life Sciences, which led the Series A financing with participation from OrbiMed, Life Sciences at Goldman Sachs Alternatives, SR One, Longitude Capital and Enavate Sciences ...
Medipost's $140 million funding will accelerate late-stage clinical development of cell-based therapies for inflammatory and degenerative conditions, enhancing global trials and regulatory preparation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results